chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right arm became red and swollen, non tender in an approximately 10 cm x 7 cm patch. No fever. No N/N.
Pt stated that the morning after the vaccine, she had trouble breathing. Weak shaking knees. Unknown if caused by the vaccine.
My right arm was very sore, I had extreme fatigue, my legs felt as if they couldn't sustain my body, I had a headache, and chills. Also, when I laid down for bed I could briefly hear my heart pounding in my ear (24 hours after receiving vaccine.  I took one 500mg acetaminophen tablet and most of the symptoms disappeared except the fatigue.
Patient received vaccine on 6-1-19 at approx 3:30pm. She returned to pharmacy on 6-3-19 informing me that she woke up early on the morning after she received the vaccine with chills, sweating and severe aches and pains everywhere (intermitant sharp pain in different areas. 24 hours later she was able to be mobile but had zero energy and could barely move her arm.  on monday 6-3-19 her arm was still red and sore and she had a low grade flu feeling but she was able to work
he started to have strokes after the 2nd Pfizer vaccination 3 days after the 2nd vaccine.
Extreme headache in eye evening after, next day, and still happening. Drooping eyelid and eyeball on left side.
This is a spontaneous report from contactable consumer, the patient. A 43year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via unspecified route of administration on 20Mar2021 at 12:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included acetaminophen; aspirin; caffeine (EXCEDRIN) for unspecified indication from unknown date. The patient previously received first dose of BNT162b2 via unspecified route of administration in the right arm on 27Feb2021 at 10:15 hours (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient previously received rizatriptan (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN), ketorolac (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE) and naproxen sodium (MANUFACTURER UNKNOWN) for unspecified indication from unknown dates and experienced drug allergy . The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient experienced very bad back mid and lower back pain on 21Mar2021 at 16:00. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of back mid and lower back pain was unknown at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Received MENACTRA vaccine 11/21/08. On same evening fever 104, general aching all over and nausea. Last approximately 24-48 hours.
Feels really bad; Aches and pains at the injection site; A spontaneous report was received from a consumer concerning a female patient of unknown age, who received Moderna's COVID-19 vaccine and experienced aches and pain at the injection site and feels really bad.  The patient's medical history was not provided. No relevant concomitant were reported.  On 05 Jan 2021, prior to the onset of the events, the patient received their dose of mRNA-1273 (lot/batch number: unknown) in the arm for prophylaxis of COVID-19 infection.    On an unknown date, the experienced aches and pain at the injection site of arm and feels really bad. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the events aches and pain at the injection site and feels really bad was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, further information has been requested.
Refused to eat the rest of the day, barely ate for 3 days following MMR vaccine. Appetite was severely decreased for 2 months following. Was seen by a different doctor, was put on Nexium for the following 2 months before appetite began to return to pre- vaccine normal.
pt recv vax AUG2796 & 7SEP96 pt devel a fever up to 104;8SPE96 pt devel acute urticaria w/pharyngitis;it was noted that pt was otherwise really healthy;9SEP96 pt was seen in clinic;strep negative;tx w/DPH;10SEp96 pt was seen by MD;
Covid vaccine x3, tested positive for COVID 09/08/2022, admit to local hospital from 09/08/2022-09/12/2022, expired 09/12/2022.
Lump or soft nodule on the right back of the head, a little above the nape and slightly red.
Site: Pain at Injection Site-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Additional Details: patient mentions he can not move left arm and that pain radiates and some time get numbness; he also mention that he did a bad movement and does not know if pain if from the bad movement or vaccine
pt recv vax @ 930AM felt some mild itching-went into clinic @ 330PM given epi & nebulizer tx vomited prior to going to clinic was weak & pale-also had diff breathing;MD told pt it was an anaphylactic from flu vax though 5hr p/vax;
Fever, chills, and fatigue.  Fever and chills resolved with use the of Ibuprofen. Mild fatigue continues
Chills; Fever; This is a spontaneous report from a contactable consumer (patient).  A 53-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EK5730, expiry: 31Mar2021), intramuscular on the left arm on 06Jan2021 13:00 at SINGLE DOSE for COVID-19 immunization  It was reported that the patient was visiting COVID-19 patients. There were no concomitant medications. The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE (lot/batch number: EK5730, expiry: 31Mar2021) intramuscular on the left arm on 16Dec2020 as COVID-19 immunization. The patient reported that he received the second dose of the Pfizer BioNTech COVID-19 vaccine yesterday (06Jan2021) and was having a minor reaction. He has chills and fever and fever this morning (07Jan2021) and wanted to know if it's okay to take over the counter ibuprofen or acetaminophen (TYLENOL). Outcome of the events were not recovered.
No adverse event; Dose administered after manufacturer date of expiry.Vaccine expiration date: 01Apr2023Vaccine administration date: 03Apr2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry.Vaccine expiration date: 01Apr2023Vaccine administration date: 03Apr2023) and NO ADVERSE EVENT (No adverse event) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 044C22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: COVID-19 VACCINE (Dose 1 and lot number: 071B22A) on 28-Feb-2023. Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE.    On 03-Apr-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry.Vaccine expiration date: 01Apr2023Vaccine administration date: 03Apr2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry.Vaccine expiration date: 01Apr2023Vaccine administration date: 03Apr2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry.Vaccine expiration date: 01Apr2023Vaccine administration date: 03Apr2023).    No concomitant medications were reported.     Patient did not report any side effects after receiving the vaccine.  No treatment medications were reported.   Reporter did not allow further contact
Initial misuse report received from a consumer on 06 November 2013. The 8-months-old patient had received 0.5 ml dose of FLUZONE QIV instead of 0.25 ml dose. No adverse event was reported. List of documents held by sender: none.
Child given vaccine that may have had temperature excursion (data logger failure) with stable fridge temps before & after. DOH determine the vaccine to be at risk & advised reporting & revaccination Child had no ill effects thus far
Cholesterol was high; Migraine; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ENG208; Expiration date was not reported) on 30Mar2021 as a 1st dose, single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. On an unspecified date in 2021, after the first dose of vaccination, the patient's cholesterol was high; and had migraine. The outcome of the events was unknown. The patient had received the second dose of vaccination on 12May2021.  No follow-up attempts are possible. No further information is expected.
covid-19; covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Physician). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 36 years for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing); "Known allergies: Almonds" (unspecified if ongoing); "known allergies: Walnuts" (unspecified if ongoing). Concomitant medication(s) included: XELJANZ, start date: 18Mar2019. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown result. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details: Product- COVID 19 Treatment,  Brand: Paxlovid, Treatment start date- 12Jun2022, Treatment stop date- 17Jun2022, Indication- Treatment of COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the Drug Ineffective and COVID-19 cannot be ruled out.
Patient reported the start of a itching hive-like rash on Tuesday night after receiving his Covid vaccine on 4/17/2021. He reports the rash continued to get worse, which prompted him to be seen by me in urgent care on 4/22/2021.  He received his first dose of the Pfizer vaccine on 4/17/2021.  No obvious anaphylaxis.  He had a uticarial rash on bilateral arms and knees.  He was tachycardic.  He refused ED visit, so I treated with 50 mg of prednisone for 5 days, oral Benadryl 50 mg every 6 hours, Pepcid 10 mg over-the-counter.  He reported he would refuse to fill out an adverse event via Vsafe app, which prompted me to file this report.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Severe, Systemic: Seizure-Mild, Systemic: Shakiness-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: Pt didn't feel good, 5 mins post vaccine. She was talking on the phone when we overheard her not feeling well. She passed out and woke up after 10 seconds. Juice and water was provided. She felt visual distrubances that recovered after 5 mins. Pt reported tightness of her throat with NO difficulty breathing, 2 tabs of benadryl was given. Pt was okay after 20 mins. Pt smelled strongly of marijuana.
Patient felt like she was going to faint .  She laid on floor and requested ambulance to come.   Patient never lost consciousness.  By the time ambulance arrived, she felt better.  EMTs walker her to her car and she drove home
After my second shot, I again had the headache, tingling down my spine, and muscle soreness, some nasal congestion. Interestingly though, on the second evening after my second shot, I developed severe pain in my muscles along my spine from my waist up to my neck. So much pain that I could not sleep, as I could get comfortable, and I could not move my arms away from my body to do anything. No reaching into the fridge, no self-care such as washing my face, brushing my teeth, getting my upper body dressed for example. This severe pain lasted for 3 days. On the 4th day, I was still hurting but was able to move my arms better & with less pain. And I could return to work.
I contracted COVID-19 on 06/21/2022 with symptoms of fatigue, body aches, headache, fever of 101.8 at highest point, chills, congestion, and diarrhea. I was prescribed Paxlovid on 06/23/2022 and 15 to 20 I took my first dose I began violently throwing up, so I only took 4 doses of it. I was ill for 6 days before my symptoms began to resolve. I am still experiencing lingering fatigue and congestion. I am not fully recovered yet.
Patient received 1 dose covid-19 vaccine 03-02-21;  and signed up for clinic for the second dose and was given different manufacturer vaccine as the second dose. had the pt sit in pharmacy for more than 45 minutes pt did not experience any effects
rect on 1JUN94 1230PM mom noted fever of 102 ax, vomited p/APAP; repeated APAP & & vomited again; skin cold, staring; took to MD in PM was told was react to shots;
I started having a headache the same day non stop, nausea and light dizziness, sensitivity to bright lights and a week after the vaccine I lost my sense of taste on my right side of my mouth. April 25th I woke up to my right side of my face paralyzed and rushed to the ER. I was diagnosed with Bell's Palsy
Knot on arm is turning black at injection site, night sweats, nauseous, throat closed- could not breathe, weak, chills, vomiting, fainted.
PUNCTURED JANSSEN VACCINE ON 20 MAY 2021 AT 11.45 AM ADMINISTERED TO A PATIENT ON 20 MAY 2021  IN THE MORNING; This spontaneous report received from a pharmacist concerned a 28 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808986 expiry: 04-JUL-2021) .5 ml, administered on 21-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 21-MAY-2021, the subject experienced punctured janssen vaccine on 20 may 2021 at 11.45 am administered to a subject on 20 may 2021 in the morning. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of punctured janssen vaccine on 20 may 2021 at 11.45 am administered to a patient on 20 may 2021 in the morning was not reported. This report was non-serious.
On 20 March she received her PCV13 (first dose) and now notes localized redness and swelling of her left shoulder at/around vaccination site for the past 24 hours. She denies constitutional and systemic symptoms. No prior adverse vaccine reactions.
Discovered a bald spot (Alopecia Areata) in December 2022, 1 month after vaccine while 5 months pregnant which got larger over course of pregnancy. After giving birth, within 1 month, I had lost all of the hair and have been diagnosed with Alopecia Universalis.
Gave first dose of Rotavirus after 15 weeks of age. Patient was 24 weeks and 4 days. No known adverse effects at this time. Was advised by CDC to report given outside of recommendation of maximum age for first dose of Rotavirus for tracking purposes.
A consumer report has been received. The report concerns a 1 month old patient. The patient's relevant history and concomitant medications were not reported. The patient had been receiving FLUMIST (intranasal) since 16-Dec-2003. The patient's mother received FLUMIST on 16-Dec-2003. She was nursing her 6.5 week old infant prior to receiving FLUMIST. It was not known if she had nursed the child prior to reading the warnings in the prescribing information. The action taken with FLUMIST was unknown. The outcome of the event of product exposure via breast milk was unknown. The company physician assessed the event of product exposure via breast milk to be non-serious.
received a mixed primary series consisting of the Pfizer as the 1st dose on 3OCT2021 and Moderna as the 2nd dose on 21DEC2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a mixed primary series consisting of the Pfizer as the 1st dose on 3OCT2021 and Moderna as the 2nd dose on 21DEC2021) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient has no medical history.  Previously administered products included for Product used for unknown indication: Pfizer vaccine (Initial dose of Pfizer vaccine) on 03-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine. Concomitant products included BUPRENORPHINE;NALOXONE for an unknown indication.    On 21-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a mixed primary series consisting of the Pfizer as the 1st dose on 3OCT2021 and Moderna as the 2nd dose on 21DEC2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a mixed primary series consisting of the Pfizer as the 1st dose on 3OCT2021 and Moderna as the 2nd dose on 21DEC2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment details were reported.  Patient has not reported any adverse reactions to the previous COVID-19 vaccine doses.
Information has been received from a licensed visiting nurse concerning a 12 month old female patient with no known drug reactions/allergies and a history of eczema who on 10-FEB-2006 was vaccinated subcutaneously with a 0.5ml dose of VARIVAX (Merck) (Lot # 652082/0943R). There was no concomitant medication. The nurse mentioned that within 42 days of vaccination the patient got chickenpox. The patient sought unspecific medical attention. The patient recovered on an unknown date. Additional information has been requested. Follow up information was received from a licensed visiting nurse concerning a now 4 year old female patient who presented to the clinic for complete physical examination. It was reported that the patient was getting the second dose of VARIVAX. It was reporte the the patient broke out in chickenpox for twi weeks after receiving initial vaccine at 12 months of age. It was reported that they lasted approximately seven days the first time. It was reported that the patient had recovered. No further informatin is available.
Patient after 10 minutes form getting the shot started to faint. family helped her to have a seat. patient  never lost consciousness, she was able to answer our questions. patient felt light headed and weak. she mentioned that her head was foggy. she felt warm and starting sweating . patient felt little better moved to out side the store.I followed her out and stayed with the family for 10 more minutes she was able stand on her own and breath normally. patient went home.I called the family at 8 pm at I was told that she is doing fine.
On 03/30 around 10pm I noticed there is a rash/redness around my injection site. It is also warm to the touch. It is about an inch tall by two inches wide.
Information has been received from a physician concerning a 15 year old female with a history of acne who on an unspecified date was vaccinated with the first dose of Gardasil which was tolerated well. On 31-AUG-2007, the patient was vaccinated with the second Gardasil. Concomitant therapy included albuterol, ALLEGRA and minocycline. No other vaccines were administered on 31-AUG-2007. In approximately August 2007, the patient experienced intermittent dizziness. The patient sought medical attention of the physician in the office. At the time of reporting, the patient's intermittent dizziness persisted. Additional information has been requested.
Within 24 hours of receiving his first flu vaccination, Patient started to drop his head involuntarily in a seizure like motion 10-15 times a day. Patient started to have a blank stare and decreased attentiveness along with disturbed sleep. Over the course of a month his episodes increased. After working with a neurologist and two EEG's, Patient was diagnosed with Benign Myoclonus of Infancy.
Pt was given a dose of Moderna vaccine that was intended for another resident.  The pt had previously received 3 doses of Pfizer vaccine (1/18/21, 2/8/21, 9/16/21).  No additional adverse effects noted.
This spontaneous prospective pregnancy report as received from a registered nurse refers to a 16 year old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-JAN-2017, the patient was vaccinated with her second dose of GARDASIL 9 intramuscularly for human papillomavirus (HPV) infection prevention (dose, lot # and expiration date were not reported). Other suspect therapies included MENACTRA, administered on the same day. On 18-JAN-2017, the nurse received test results of the patient being 3 weeks pregnant. Her last menstrual period (LMP) was on 28-DEC-2016 and her estimated date of delivery (EDD) was 04-OCT-2017 (calculation based on being 3 weeks pregnant on 18-JAN-2017). Initial exposure to GARDASIL 9 was at 2 weeks. The pregnancy outcome was pending. The nurse would tell the patient and her parents about the pregnancy on 19-JAN-2017, as they were unaware of it at the time of the report. The patient did not receive any treatment. Additional information has been requested.
Headache, Fever, CHILLS, FATIGUE Narrative: STATES AFTER FIRST INJECTION HAD PAIN AT  INJECTION SITE, FATIGUE, HEADACHE, CHILLS FEVER, MYALGIAS, LASTED 2 DAYS  Other Relevant History:
Slight bruising with a rash around the area of the injection sight, itchy and sore
7/21--7/23 29y.o. G1P0 at 39w5d by L=8 5/7 wk US presents to Triage with c/o ctxs and LOF  @ 0700. Fetal movement normal. 7/21 SVD healthy baby. Discharged with baby 7/23.
After one week, I developed a warm, raised and slightly itchy thickened area at the injection site.
Pediarix and Prevnar administered left thigh. Hib administered right thigh. Left thigh 5cm firm, erythema, swelling. Right thigh 2cm firm, erythema, swelling. Additional terms entered 12/29/05 from discharge summary is somnolance, from medical records, infect viral.
90 seconds after L deltoid injection patient developed blotchy redness. Initially on chest, moving to neck and face. Patient felt "faint". Treatment consisted of having patient lie down, legs elevated, cold compress on forehead. After 30 minutes patient okay.
Patient reported arm soreness at injection site. Then on day 4 she felt numbness and tingling down arm and into fingers. Also felt that glands in neck were swollen and tender. Also, soreness in knees, ankle, and feet making it difficult to walk. Patient self treated with BENADRYL and TYLENOL. Symptoms went away after 30 minutes.